Kloramfenikol (Chloramphenicol)

Chloramphenicol binds to the bacterial 50S ribosomal subunit, blocking peptide bond formation and halting protein synthesis. This bacteriostatic action limits the growth of susceptible Gram‑positive and Gram‑negative organisms that cause ocular infections.

The dosing regimen for Kloramfenikol is determined by the prescribing clinician based on the type and severity of the eye infection, patient age and response to therapy. The prescriber will specify the number of drops, frequency and duration of treatment.

Safety data for chloramphenicol eye drops in pregnancy and lactation are limited. Use only if the potential benefit justifies any potential risk to the fetus or infant, and discuss with a healthcare professional before starting therapy.

To order Kloramfenikol, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping details and any necessary import documentation.

Compared with other topical antibiotics such as fluoroquinolones, chloramphenicol offers a broad spectrum against both Gram‑positive and Gram‑negative bacteria and is often used where resistance to newer agents is a concern. However, it may have a higher risk of rare systemic side effects, so choice depends on clinical judgment.

Store Kloramfenikol at ambient temperature, below 25 °C, in its original container. Protect the solution from moisture, direct sunlight and extreme temperatures to maintain stability and potency.

Kloramfenikol is applied as eye drops. The prescribed number of drops is placed into the conjunctival sac of the affected eye(s) at the intervals indicated by the prescriber, usually without touching the tip to the eye or surrounding tissues.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and rare systemic bone‑marrow suppression leading to aplastic anemia. Immediate medical attention is required if any of these symptoms develop.

Patients with a known hypersensitivity to chloramphenicol or other amphenicol antibiotics should avoid Kloramfenikol. Caution is also advised for individuals with a history of bone‑marrow disorders, and it should be used only when clearly needed during pregnancy or lactation.